Interaction Between the Central and Peripheral Effects of Insulin in Controlling Hepatic Glucose Metabolism in the Conscious Dog

  1. Dale S. Edgerton1
  1. 1Vanderbilt University School of Medicine, Department of Molecular Physiology and Biophysics, Nashville, Tennessee
  2. 2Medical College of Georgia at Georgia Health Sciences University, Department of Cellular Biology and Anatomy, Augusta, Georgia
  3. 3Vanderbilt University School of Medicine, Division of Surgical Research, Nashville, Tennessee
  1. Corresponding author: Dale S. Edgerton, dale.edgerton{at}vanderbilt.edu.

Abstract

The importance of hypothalamic insulin action to the regulation of hepatic glucose metabolism in the presence of a normal liver/brain insulin ratio (3:1) is unknown. Thus, we assessed the role of central insulin action in the response of the liver to normal physiologic hyperinsulinemia over 4 h. Using a pancreatic clamp, hepatic portal vein insulin delivery was increased three- or eightfold in the conscious dog. Insulin action was studied in the presence or absence of intracerebroventricularly mediated blockade of hypothalamic insulin action. Euglycemia was maintained, and glucagon was clamped at basal. Both the molecular and metabolic aspects of insulin action were assessed. Blockade of hypothalamic insulin signaling did not alter the insulin-mediated suppression of hepatic gluconeogenic gene transcription but blunted the induction of glucokinase gene transcription and completely blocked the inhibition of glycogen synthase kinase-3β gene transcription. Thus, central and peripheral insulin action combined to control some, but not other, hepatic enzyme programs. Nevertheless, inhibition of hypothalamic insulin action did not alter the effects of the hormone on hepatic glucose flux (production or uptake). These data indicate that brain insulin action is not a determinant of the rapid (<4 h) inhibition of hepatic glucose metabolism caused by normal physiologic hyperinsulinemia in this large animal model.

Footnotes

  • Received February 13, 2012.
  • Accepted June 22, 2012.

Readers may use this article as long as the work is properly cited, the use is educational and not for profit, and the work is not altered. See http://creativecommons.org/licenses/by-nc-nd/3.0/ for details.

| Table of Contents

This Article

  1. Diabetes vol. 62 no. 1 74-84
  1. Supplementary Data
  2. All Versions of this Article:
    1. db12-0148v1
    2. 62/1/74 most recent